|
Editorial
Global biotech
hub
Edit Article
Judicious
implementation of TRIPs
|
Product
patent regime: A threat or boon!
Domestic companies may look forward to undertake and
support collaborative research with academic and research
institutions. This will avoid duplication of infrastructure
and optimise utilisation of our talents, say Dr Guru
Prasad Mohanta, Dr Prabal Kumar Manna and
Dr R Manavalan.
|
|
Panacea
Biotec introduces anti-allergy drug
Cadila
gets DCGI nod for phase I trial of NME
Ranbaxy
acquires generic product portfolio from Efarmes
Orchid’s
Chennai R&D centre receives GLP certification
Millipore
wins US Environment Protection Agency Award
Emcure
signs MoU with Iceland-based Actavis Pharma
German
Remedies launches Betaferon for multiple sclerosis
|
Experts
recommend national standards to improve trauma care
In an attempt to curb the high mortality rate due to
injury and to ameliorate the status of Emergency Medical
Services (EMS) in India, trauma experts from WHO, national
medical associations, medical institutions and various
state governments, have submitted a roadmap to address
the growing burden of injury in the country to Union
Ministry of Health and Family Welfare, last month.
|
|
Frost
& Sullivan organises Global Partnership Summit
Frost & Sullivan, the global growth consulting company
organised a global partnership summit on life-science
molecules, recently in Goa. The conference was inaugurated
by Aroop Zutshi, Senior Partner of Frost & Sullivan.
|
TA
Instruments launches Q5000 SA thermogravimetric moisture
sorption analyzer
TA Instruments, (New Castle, DE) has introduced the
Q5000 SA, a high performance moisture sorption analyzer,
said a release issued by the company.
|
|
‘Industry
must leverage technological innovations to maximise
profits’
Millipore is a high-tech bioscience company that provides
technologies, tools and services for the development
and production of new therapeutic drugs. Senior officials
from Millipore, Julian Alonso, Director (Millipore India);
Michel Bourderioux, Technology and Sales Support Manager
(Europe); M S Mahadevan, Vice-President, Biopharmaceutical
Division, Millipore-India and H S Dayananda, Business
Manager in a tete-e-tete with R BabyManoj share
information on Millipore and its operations.
|
Pharmacy
in India: At crossroads
Harmonisation of pharmacy education has to be made a
global agenda that will encompass the developments that
have taken place in basic, medical, pharmaceutical sciences
in serving the needs and expectations of society, feel
Dr P G Yeole and M P Puranik
|
